A team from law firm Stone King has raised over £6,000 for charity after cycling from Bath to London.
The intrepid cyclists covered the 155-mile distance on June 10 and 11, with their pedal power raising money for Cancer Research UK.
Nine riders took part, setting out from the firm’s Bath office at Upper Borough Walls and finishing at its London office in the Barbican.
So far the team have raised £6,255, boosted by a £1,500 donation from the firm’s charitable arm the Stone King Foundation.
There was a poignant reason for the fundraiser – the ride was the brainchild of Stone King Chair Alison Allen, who had treatment for cancer last year.
“We know that this disease affects one in two of us and I am extremely fortunate to benefit from the huge amount of research that has gone before me,” she said.
“Thankfully, for many people today, cancer is not a death sentence because of the life-saving research funded by charities like CRUK and this ride is a positive demonstration of that.
“However, I am also acutely aware that I am one of the lucky ones and there are so many people who are not as fortunate; there will be many others within the family of Stone King and beyond who have been affected by cancer.
“The ride was tough going at times but made so much easier by the camaraderie in the team and the welcome support during the event from Lee Coley and Katherine Neylan.”
The Stone King team was: Alison Allen, Philip Askew, Andrew Banks, Ollie Daw, Sophie Pughe, Frances Reynolds, Jamie Telling, Jessica Ventham and Peter Woodhouse.
Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research, influence and information. It supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
There is still time to support the riders here.
Join Somerset Chamber of Commerce to give your business a stronger voice both locally, regionally and nationally. Combined with local town chambers, we represent over 2,000 businesses across Somerset with a direct line to policy-makers at all levels.